C3-convertase

Structure of C3-convertase

C3-convertase is a key enzyme involved in the complement system, which is an important part of the immune response in vertebrates. It plays a crucial role in the activation of the complement cascade, leading to the elimination of pathogens and the clearance of immune complexes.

Structure

C3-convertase is a complex enzyme that consists of multiple subunits. It can be formed through two different pathways: the classical pathway and the alternative pathway. In the classical pathway, C3-convertase is formed by the cleavage of C4 and C2 proteins, while in the alternative pathway, it is formed by the cleavage of C3 protein.

The structure of C3-convertase varies depending on the pathway through which it is formed. In the classical pathway, C3-convertase is composed of C4b and C2a subunits, while in the alternative pathway, it consists of C3bBb subunits. These subunits come together to form a stable enzyme complex that efficiently cleaves C3 protein.

Function

The main function of C3-convertase is to cleave C3 protein into C3a and C3b fragments. This cleavage is a crucial step in the complement cascade, as it leads to the activation of downstream components and the amplification of the immune response.

C3a fragment acts as an anaphylatoxin, promoting inflammation and attracting immune cells to the site of infection. On the other hand, C3b fragment plays a key role in opsonization, which is the process of marking pathogens for phagocytosis by immune cells. C3b also participates in the formation of the membrane attack complex (MAC), which can directly lyse pathogens.

Regulation

The activity of C3-convertase is tightly regulated to prevent excessive complement activation and potential damage to host tissues. Several regulatory proteins, such as factor H and factor I, are involved in the control of C3-convertase activity.

Factor H acts as a cofactor for factor I, promoting the degradation of C3b and preventing the formation of C3-convertase. This regulatory mechanism helps to maintain a delicate balance between complement activation and host protection.

Clinical Significance

Dysregulation of C3-convertase activity can lead to various diseases and disorders. For example, deficiencies in regulatory proteins like factor H can result in uncontrolled complement activation, leading to conditions such as atypical hemolytic uremic syndrome (aHUS) and age-related macular degeneration (AMD).

Furthermore, excessive activation of C3-convertase can contribute to autoimmune diseases, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). In these conditions, the immune system mistakenly attacks the body's own tissues, causing chronic inflammation and tissue damage.